French government losing control over spending?
This article was originally published in Clinica
French healthcare spending is spiralling upwards again after having been bought strictly under control. It rose by 6% in 2000, FF18 billion ($2.55 billion) over the national healthcare expenditure budget, which had planned a 2.5% increase. This compares with a 2.9% increase in 1999.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.